Canaccord Genuity Reiterates a 'Buy' on St. Mary's (SM); A Mid-Cap Favorite - Expect Strong Growth in Output
SM Hot Sheet
Rating Summary:14 Buy, 3 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 82
Canaccord Genuity reiterates a 'Buy' on St. Mary's (NYSE: SM) price target of $123.00.
Analyst, John Gerdes, said, "We believe SM should report stronger-than-expected Q4/11 and Q1/12 production and at least double Galvan Ranch drilling locations this year. SM shares have twice the upside to our target as the group. SM trades at a 10% discount (’12E EBITDA), yet we believe it should generate ~40% greater CFPS growth (’11-’13E) than the sector. We project SM should spend ~40% beyond cash flow this year while the group outspends cash generation by ~30%."
For an analyst ratings summary and ratings history on St. Mary's click here. For more ratings news on St. Mary's click here.
Shares of St. Mary's closed at $76.81 yesterday, with a 52 week range of $53.45-$88.50.
Discover Wall Street's best ratings calls with the pros - Ratings Insider Elite. Free Trial!
Analyst, John Gerdes, said, "We believe SM should report stronger-than-expected Q4/11 and Q1/12 production and at least double Galvan Ranch drilling locations this year. SM shares have twice the upside to our target as the group. SM trades at a 10% discount (’12E EBITDA), yet we believe it should generate ~40% greater CFPS growth (’11-’13E) than the sector. We project SM should spend ~40% beyond cash flow this year while the group outspends cash generation by ~30%."
For an analyst ratings summary and ratings history on St. Mary's click here. For more ratings news on St. Mary's click here.
Shares of St. Mary's closed at $76.81 yesterday, with a 52 week range of $53.45-$88.50.
Discover Wall Street's best ratings calls with the pros - Ratings Insider Elite. Free Trial!
You May Also Be Interested In
- UBS Lowers Estimates and PT on Lowe's (LOW) Messy Q1, But Bullish Case Remains
- Barclays maintains an 'Equalweight' on Tech Data (TECD); Slight Adjustments on Q1 Results
- Oppenheimer Reiterates an 'Outperform' on MakeMyTrip (MMYT); Updating Estimates Ahead of March Qtr
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS ViewRelated Entities
Genuity Capital MarketsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
